MARKET WIRE NEWS

Overweight Recommendation Issued On CTMX By Barclays

Source: KlickAnalytics

2025-10-21 06:15:05 ET

  • Barclays analyst issues OVERWEIGHT recommendation for CTMX on October 21, 2025 09:19AM ET.
  • The previous analyst recommendation was Overweight.
  • CTMX was trading at $3.74 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 15 - Buy, 6 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Full story available on KlickAnalytics.com
    CytomX Therapeutics Inc.

    NASDAQ: CTMX

    CTMX Trading

    -1.58% G/L:

    $4.675 Last:

    1,737,279 Volume:

    $4.90 Open:

    mwn-link-x Ad 300

    CTMX Latest News

    CTMX Stock Data

    $945,449,504
    141,817,426
    0.97%
    31
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    South San Francisco

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App